Caracterización de eventos hipoglicémicos en niños y adolescentes con diagnóstico de diabetes mellitus tipo 1
Resumen
Introducción: Los pacientes con diagnóstico de diabetes mellitus 1 (DM1) presentan con alta frecuencia eventos hipoglicémicos que pueden llegar a ser severos y generar complicaciones a largo plazo.
Objetivos: Caracterizar hipoglicemias manifestadas en niños y adolescentes con diagnóstico de DM1 asistentes al campamento de verano de la Fundación de Diabetes Juvenil en enero, 2016.
Materiales y Métodos: Estudio descriptivo analítico de corte transversal basado en encuestas autoaplicadas realizadas en 102 niños y adolescentes.
Resultados: Los síntomas que se presentaron con mayor frecuencia fueron astenia y temblor. El horario más frecuente de presentación fue durante la tarde seguido por la noche. Hubo diferencia significativa en los niveles de hemoglobina glicosilada (HbA1C) entre los pacientes que han cursado con hipoglicemia severa y aquellos sin aquel antecedente (7.8% v/s 11.2 %, p=0.013).
Discusión: La sintomatología en episodios hipoglicémicos es inespecífica y se manifiesta en horarios de menor vigilancia por lo que es primordial identificar los factores de riesgo de desarrollarlos y plantear un control metabólico individualizado.
Palabras clave:
diabetes mellitus 1, hipoglicemia, hemoglobina glicosiladaReferencias
(1) Ly TT, Maahs DM, Rewers A, et al. ISPAD Clinical Practice Consensus Guidelines 2014. Assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatr Diabetes 2014; 15 Suppl 20: 180.
(2) Seaquist ER, Anderson J, Childs B, et al. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. J Clin Endocrinol Metab 2013; 98: 1845.
(3) Hypoglycemia in children and adolescents with type 1 diabetes mellitus. Authors Lynne L Levitsky, MD Madhusmita Misra, MD, MPH Oct 08, 2014.
(4) DeRosa MA, Cryer PE. Hypoglycemia and the sympathoadrenal system: neurogenic symptoms are largely the result of sympathetic neural, rather than adrenomedullary, activation. Am J Physiol Endocrinol Metab 2004; 287: E32.
(5) Kaufman FR, Austin J, Neinstein A, et al. Nocturnal hypoglycemia detected with the Continuous Glucose Monitoring System in pediatric patients with type 1 diabetes. J Pediatr 2002; 141: 625.
(6) Rewers MJ, Pillay K, de Beaufort C, et al. ISPAD Clinical Practice Consensus Guidelines 2014. Assessment and monitoring of glycemic control in children and adolescents with diabetes. Pediatr Diabetes 2014; 15 Suppl 20: 102.
(7) Chiang JL, Kirkman MS, Laffel LM, et al. Type 1 diabetes through the life span: a position statement of the American Diabetes Association. Diabetes Care 2014; 37: 2034.
(8) American Diabetes Association. Standards of medical care in diabetes--2014. Diabetes Care 2014; 37 Suppl 1: S14.
(9) Cryer PE. Hypoglycemia in diabetes: Pathophysiology, prevalence, and prevention, 2nd, American Diabetes Association, Alexandria, VA 2012.
(10) Felner EI, Klitz W, Ham M, et al. Genetic interaction among three genomic regions creates distinct contributions to early and late-onset type 1 diabetes mellitus. Pediatr Diabetes 2005; 6: 213.
(11) Writing Group for the SEARCH for Diabetes in Youth Study Group, Dabelea D, Bell RA, et al. Incidence of diabetes in youth in the United States. JAMA 2007; 297: 2716.
(12) Kalyva E, Malakonaki E, Eiser C, Mamoulakis D. Health-related quality of life (HRQoL) of children with type 1 diabetes mellitus (T1DM): self and parental perceptions. Pediatr Diabetes 2011; 12: 34.
(13) Kaufman FR, Austin J, Neinstein A, et al. Nocturnal hypoglycemia detected with the Continuous Glucose Monitoring System in pediatric patients with type 1 diabetes. J Pediatr 2002; 141: 625.
(14) Cengiz E, Xing D, Wong JC, et al. Severe hypoglycemia and diabetic ketoacidosis among youth with type 1 diabetes in the T1D Exchange clinic registry. Pediatr Diabetes 2013; 14: 447.
(15) Marrero DG, Guare JC, Vandagriff JL, Fineberg NS. Fear of hypoglycemia in the parents of children and adolescents with diabetes: maladaptive or healthy response? Diabetes Educ 1997; 23: 281.
(16) Thomas CC, Philipson LH. Update on diabetes classification. Med Clin North Am. 2015; 99: 1-16.
(17) American Diabetes Association. Standards of medical care in diabetes-2014. Diabetes Care. 2014; 37: S14-8.
(18) Morran MP, Vonberg A, Khadra A, Pietropaolo M. Immunogenetics of type 1 diabetes mellitus. Mol Aspects Med. 2015; 42: 42-60.
(19) Rewers MJ, Pillay K, de Beaufort C, Craig ME, Hanas R, Acerini CL, et al. International Society for Pediatric and Adolescent Diabetes. ISPAD Clinical Practice Consensus Guidelines 2014. Assessment and monitoring of glycemic control in children and adolescents with diabetes. Pediatr Diabetes. 2014; 15: S102-14.
(20) Tauschmann M, Hovorka R. Insulin pump therapy in youth with type 1 diabetes: toward closed-loop systems. Expert Opin Drug Deliv. 2014; 11: 943-55.
(21) Smart CE, Annan F, Bruno LP, Higgins LA, Acerini CL; International Society for Pediatric and Adolescent Diabetes. ISPAD Clinical Practice Consensus Guidelines 2014.
